Ignite Creation Date:
2024-05-06 @ 9:39 AM
Last Modification Date:
2024-10-26 @ 12:17 PM
Study NCT ID:
NCT03031717
Status:
UNKNOWN
Last Update Posted:
2020-03-02
First Post:
2017-01-23
Brief Title:
Clinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPS
Sponsor:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Organization:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Study Overview
Official Title:
Follow-up and Survival of Cirrhotic and Non Cirrhotic Patients With Portal Vein Thrombosis Treated With Transjugular Intrahepatic Portosystemic Shunt
Status:
UNKNOWN
Status Verified Date:
2020-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Portal vein thrombosis PVT is defined as an obstruction of the portal vein The prevalence of PVT is 10-25 and incidence is about 16 in cirrhotic patients PVT leads to increased intrahepatic resistance decreased portal velocities splanchnic vasodilatation and stagnant flow
Portal vein recanalization PVR with transjugular intrahepatic portosystemic shunt TIPS is aimed at restoring main portal vein PV flow in chronic PVT In this study we will review the safety and outcomes of this approach
Portal vein recanalization PVR with transjugular intrahepatic portosystemic shunt TIPS is aimed at restoring main portal vein PV flow in chronic PVT In this study we will review the safety and outcomes of this approach
Detailed Description:
Portal vein thrombosis PVT is a fairly common complication of liver cirrhosis Importantly occlusive PVT might influence the prognosis of patients with cirrhosis Transjugular intrahepatic portosystemic shunt TIPS has been reported to be an effective treatment of PVT in cirrhosis with the advantage of avoiding the risk of bleeding linked to anticoagulation In this study we will evaluate the outcome of TIPS for PVT in patients with and without cirrhosis and determinate survival
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None